StonvexLoading…
StonvexStonvexStonvexCore line items from DSGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Annual 2020 2020-12-31 | Q3 2020 2020-09-30 | Q2 2020 2020-06-30 | Q1 2020 2020-03-31 |
|---|---|---|---|---|---|
Revenue | $0.00 | $226.00K | $193.00K | $173.00K | $142.00K |
Operating Income | Not available | $-8.33M | $-4.47M | $-2.09M | $-623.00K |
Net Income | Not available | $-8.28M | $-4.42M | $-2.10M | $-663.00K |
EPS (Diluted) | $-0.35 | Not available | Not available | Not available | Not available |
Total Assets | Not available | $36.52M | Not available | Not available | Not available |
Total Liabilities | Not available | $2.48M | Not available | Not available | Not available |
Cash & Equivalents | Not available | $2.38M | $3.22M | $1.90M | $2.70M |
Free Cash Flow OCF − CapEx | Not available | $-8.74M | $-5.89M | Not available | Not available |
Shares Outstanding | Not available | 15.96M | Not available | Not available | Not available |